State of BCI 2026 Annual Industry Report: $3.2B market, $1.6B raised 2025-2026 YTD, clinical trial landscape
Summary
BCIintel published the State of BCI 2026 Annual Industry Report — compiled from primary and secondary sources and refreshed continuously by an autonomous monitoring agent. Key data: global BCI market valued at $2.8B in 2025 / $3.2B estimated 2026, projected $6-12B by 2030 at 15-18% CAGR; $1.6B+ raised in disclosed VC/institutional funding in 2025-2026 YTD; total disclosed BCI investment since 2018 exceeds $3B. Largest round: Neuralink $650M Series E at $9B valuation (June 2025). Market bifurcating: clinical invasive BCI vs consumer non-invasive. Companies with active human trials, FDA approvals, or commercial products represent >90% of disclosed BCI investment.
Why it matters
The State of BCI 2026 is the most comprehensive single-source public overview of BCI industry data available, compiled by a dedicated intelligence platform using automated monitoring. The $3.2B market size from three aggregated research firm estimates and $1.6B+ YTD funding figure from disclosed rounds provides the benchmarks that investors, strategists, and companies use to size the opportunity and track sector momentum.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial